Blood cell labelling. Theory and methods: radiation hazards.

Area of Science:

• Nuclear Medicine
• Radiochemistry
• Medical Physics

Background:

• Comparison of radionuclide properties is crucial for optimizing radiopharmaceutical applications.
• Indium-111 (In111), Technetium-99m (Tc99m), Iodine-131 (I131), and Chromium-51 (Cr51) are commonly used radionuclides in nuclear medicine.
• Understanding physical properties like gamma-ray penetration is essential for radiation safety and imaging efficacy.

Purpose of the Study:

• To outline the physical properties of Indium-111 (In111).
• To compare In111 with Tc99m, I131, and Cr51 for similar applications.
• To discuss the implications of In111's gamma-ray penetration on shielding and dosimetry.

Main Methods:

• Review and comparison of the physical characteristics of In111, Tc99m, I131, and Cr51.
• Analysis of gamma-ray penetration through lead for In111 and Tc99m.
• Examination of dosimetry data for In111-labeled cells in human subjects.

Main Results:

• In111 gamma-rays exhibit significantly greater penetration in lead compared to Tc99m.
• This increased penetration necessitates specific considerations for syringe shielding and lead glass screens.
• Dosimetry indicates that In111-labeled cell injections can result in absorbed doses of approximately 10 rad (0.1 Gy) to the spleen per mCi (37 MBq) injected.

Conclusions:

• The superior gamma-ray penetration of In111 compared to Tc99m has direct implications for radiation safety protocols in nuclear medicine.
• Radiation damage, rather than oxine labeling, is now considered the cause of observed cell damage in In111 studies.
• Accurate dosimetry is vital for In111 applications to manage radiation exposure and ensure patient safety.